New COVID-19 Data Gives This Stock a Boost

Athleisure Company Struggles in Premarket After Lowering Gross Margin Expectations‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Good morning Wake-Up Watchlisters! It's Monday, and you know what means. Our Head Trading Tactician Nate Bear is giving you his weekly stocks to watch. Today he's got three names he wants to go over. You won't want to miss this one. Click the image below to see what's in store this week. And while you're sipping coffee you'll see stock futures were up again on Monday. The markets are looking to sustain Friday's big rally, which saw all three major indexes soar. This upward trend came after signs of cooling wage growth from December employment data. For the week, the S&P 500 and Dow Jones Industrial Average each advanced 1.5%. Attention Traders: We've got huge news. We have a new technology that's more than 20 years in the making. This new tool could help you find winning trade patterns faster than ever. And we're going to show you exactly how it works for FREE on Wednesday, January 11 at 2 p.m. EST. Click here to get on the guest list for our Accelerated Profits Summit Live. Here's a look at the top-moving stocks this morning. CureVac N.V. (Nasdaq: CVAC) CureVac N.V. is up 27% premarket after new preliminary data from its early stage trial of COVID-19 and seasonal flu shots showed positive results. CureVac said the COVID-19 shot was well tolerated, and that neutralizing antibodies were beginning at the lowest tested dose for younger adults. When it comes to investing in innovative medical companies, it's crucial to consider companies that haven't popped yet. That's why our friend Alexander Green is pounding the table on a company that has the patent on a medical device that could be the biggest breakthrough in 37 years – and it's trading for under $3 right now. Click here to unlock this stock. Exact Sciences (Nasdaq: EXAS) Exact Sciences is up 14% premarket after announcing its latest fourth quarter results. The leading cancer screening company posted a 28% revenue increase compared to the fourth quarter 2021. It also announced expected revenue between $550.7 million and $552.7 million, an increase of 16%. Get Marc's Top 5 Dividend Stocks (FREE PICKS) World-renowned income expert Marc Lichtenfeld just released his Ultimate Dividend Package. Inside, you'll find his TOP FIVE dividend stocks right now. And today, he's giving you this package... completely free of charge! To get your FREE dividend recommendations, click here now. Lululemon Athletica (Nasdaq: LULU) Lululemon is down 12.22% premarket after the clothing retailer said it now expects gross margin for its fourth quarter fiscal 2022 to decline by 90-110 basis points, having previously expected an increase of 10-20 basis points. The company's gross margin in the fourth quarter of fiscal 2023 was 58.1%. Those are the top market movers today. Happy trading! The Wake-Up Watchlist Research Team Putin's Spiteful Behavior Could Make Americans Rich??   Source: www.kremlin.ru   One company is already generating record profits. In fact, Wall Street projects one $30 stock will rise to $280 in just 18 months... all thanks to a HUGE mistake by Russia's president. Here's what you need to know... Monument Traders Alliance   You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 Website | Privacy Policy Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day. © 2022 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.